Deleted No
Hibernated Yes
Last Checked July 11, 2022

Created

Wed May 11 10:33:16 +0000 2022

Likes

9

Retweets

2

Source

SocialFlow

View Raw Data

JSON Data

View on Twitter

Likely Available
Profile Image

Axios @axios

A week after the maker of a controversial Alzheimer's drug announced it would largely stop marketing it, Congress is readying legislation that tinkers with the pathway used by the FDA to approve the drug, but avoids making large-scale changes. https://t.co/1RqERFoaaN — PolitiTweet.org

Posted May 11, 2022 Hibernated